Radiopharm Theranostics Files 6-K
Ticker: RDPTF · Form: 6-K · Filed: Jun 2, 2025 · CIK: 1949257
| Field | Detail |
|---|---|
| Company | Radiopharm Theranostics Ltd (RDPTF) |
| Form Type | 6-K |
| Filed Date | Jun 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, filing-update
TL;DR
Radiopharm Theranostics (RPT) filed a 6-K, confirming 20-F annual report filings.
AI Summary
Radiopharm Theranostics Limited filed a Form 6-K on June 2, 2025, reporting information as a foreign private issuer. The company is incorporated in Australia and its principal executive office is located in Carlton South, Victoria. This filing indicates the company will file annual reports under cover of Form 20-F.
Why It Matters
This filing provides routine updates for foreign private issuers, informing investors about the company's reporting status and administrative details.
Risk Assessment
Risk Level: low — This is a routine administrative filing by a foreign private issuer and does not contain new financial or operational information.
Key Players & Entities
- Radiopharm Theranostics Limited (company) — Registrant
- 001-41621 (company) — SEC File Number
- Form 20-F (company) — Annual Report Filing
- June 2, 2025 (date) — Filing Date
FAQ
What type of filing is this for Radiopharm Theranostics Limited?
This is a Form 6-K, a Report of Foreign Private Issuer.
When was this Form 6-K filed?
The filing was made on June 2, 2025.
Under which form will Radiopharm Theranostics Limited file its annual reports?
The company will file annual reports under cover of Form 20-F.
What is the principal executive office address for Radiopharm Theranostics Limited?
The principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
Does Radiopharm Theranostics Limited furnish information under Rule 12g3-2(b)?
No, the registrant indicated 'No' for furnishing information under Rule 12g3-2(b).
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 2, 2025 regarding Radiopharm Theranostics Ltd (RDPTF).